Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × niraparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 15 Breast Neoplasms 6 Neoplasms 5 Fallopian Tube Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Esophageal Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Stomach Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Mesothelioma 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡